64.2 F
New York
HomeHealth

Health

HR HealthCare Advances Patient-Centered Care with New Supply Division

HR HealthCare Patient Services will operate as a supply division of HR HealthCare Medical supply processing capabilities will enable an end-to-end care management solution A cohesive brand strategy aims to promote transparency and focus on enhanced continuity of care YORK, Pa., Oct. 11, 2024 /PRNewswire/ -- HR HealthCare,...

Kessler Foundation 2024 Survey Highlights Key Strategies for Hiring and Supporting Workers with Disabilities in the Hospitality Industry

Supervisors share impressions related to recruiting, hiring, and providing workplace accommodations and effectiveness of those methodsEAST HANOVER, N.J., Oct. 11, 2024 /PRNewswire/ -- A new Kessler Foundation survey of supervisors in the hospitality industry – focused on restaurant and traveler accommodations – has revealed critical...

SANLUCAR RECOGNIZED AS LEADER IN FRESH PRODUCE AT GLOBAL BRAND AWARDS 2024

LONDON, Oct. 11, 2024 /PRNewswire/ -- SanLucar wins 2024 "Excellent Brand Reputation in Fresh Produce, Europe" award at the esteemed Global Brand Awards.   The Global Brand Awards, hosted annually by Global Brands Magazine (GBM) in England, celebrate top brands across various industries. Global Brands Magazine...

Cell Therapy 2.0: The Rise of Automation and Closed Systems

"A worldwide industry that uses advanced technology to simplify and improve cell therapy, making it faster, safer, and more accessible for patients globally. BCC Research Study Projects a 23.9% CAGR, with Market Growth from $1.8 Billion in 2024 to $5.3 Billion by 2029" BOSTON, Oct. 11,...

Aetna recommended for new D-SNP contract by the State of Michigan

Aetna to support more Michigan residents eligible for both Medicare and MedicaidDETROIT, Oct. 11, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to serve MI Coordinated Health beneficiaries who...

FDA Approves New Treatment for Hemophilia A or B

Product is First Non-Factor and Once-Weekly Treatment for Hemophilia B SILVER SPRING, Md., Oct. 11, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients...
- Advertising -
- Advertising -Miami clinic
- Advertising -Kiev plastic surgery
- Advertising -
- Advertising -
- Advertising -